Last reviewed · How we verify
bupivicaine epidural
At a glance
| Generic name | bupivicaine epidural |
|---|---|
| Also known as | Marcaine |
| Sponsor | MemorialCare |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The PAIN (Pelvic Area Injection for Numbness) Study (PHASE4)
- Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery (PHASE3)
- Comparison of Epidural and TAP Block in Abdominal Surgery
- Prolotherapy Versus Epidural Steroid Injections (ESI) for Lumbar Pain Radiating to the Leg (PHASE4)
- Epidural for Ogilvie's Syndrome (NA)
- Saphenous Nerve Block Versus Femoral Nerve Block for Total Knee Arthroplasty (NA)
- A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia (PHASE4)
- Comparison of Three Different Pain Blocks for Subjects Undergoing VATS (Video Assisted Thoracoscopic Surgery) Procedure. (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- bupivicaine epidural CI brief — competitive landscape report
- bupivicaine epidural updates RSS · CI watch RSS
- MemorialCare portfolio CI